지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이 논문의 연구 히스토리 (2)
- 이 논문의 후속연구가 궁금하신가요?
- 연관 학술논문 또는 학술발표를 통해 보다 발전된 연구결과를 확인하실 수 있습니다.
- 이 논문의 연구 히스토리 확인하기
초록· 키워드
오류제보하기
Objective: To analyze osteoporosis treatment patterns and teriparatide prescription-associated factors in Korea by using a national health insurance claims database. Methods: We utilized the Health Insurance Review & Assessment Service National Patients Sample claims database to identify patients (aged ≥50 years) with at least one osteoporosis claim (International Classification of Disease 10th revision code: M80, M81, M82) and at least one prescription for osteoporosis medication (antiresorptive agents: bisphosphonates, selective estrogen receptor modulators, denosumab, and calcitonin; bone-forming agent: teriparatide) in 2018. Demographic characteristics and healthcare utilization patterns were analyzed. Factors associated with teriparatide prescriptions were assessed using a multivariate logistic regression model. Results: Records showed that 44,815 patients were prescribed osteoporosis medications in 2018; the percentage of patients prescribed each treatment was as follows: 86.6% bisphosphonates, 13.9% selective estrogen receptor modulators, 3.1% calcitonin, 2.1% denosumab, and 0.7% teriparatide. A greater proportion of patients prescribed teriparatide were ≥75 years (53.4% vs. 33.8%) and had fractures (63.9% vs. 12.8%) compared to the same for antiresorptives (p<0.001). Patients prescribed teriparatide had higher Charlson comorbidity index values (1.2±1.3 vs. 0.9±1.2) and were more frequently hospitalized (0.8±1.3 vs. 0.1±0.5) than those prescribed antiresorptives (p<0.001). Elderly patients (≥75 years old; adjusted OR=1.66; 95% CI 1.16-2.38) and those with fractures (adjusted OR=6.23; 95% CI 4.76-8.14) were more likely to be prescribed teriparatide than antiresorptives. Conclusion: Patients prescribed teriparatide were older and more likely to have severe osteoporosis than those prescribed antiresorptives.
목차
등록된 정보가 없습니다.
참고문헌 (11)
참고문헌 신청
Korean Society for Bone and Mineral Research / 2018 / Physician’s Guide for Osteoporosis 2018 / Korean Society for Bone and Mineral Research :12
Korean Society for Bone and Mineral Research / 2019 / Osteoporosis and Osteoporotic Fracture Fact Sheet 2019 / Korean Society for Bone and Mineral Research :5~6
Lee EH / 2019 / Socioeconomic Burden of Disease Due to Osteoporosis in South Korea :58
Camacho PM / 2020 / American association of clinical endocrinologists/american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update / Endocr Pract 26(Suppl 1):1~46
Health Insurance Servie & Assessment Service Bigdata Hub / Guidance for National Sample Claims Database
Korean Society for Bone and Mineral Research / 2019 / Osteoporosis and Osteoporotic Fracture Fact Sheet 2019 / Korean Society for Bone and Mineral Research :5~6
Lee EH / 2019 / Socioeconomic Burden of Disease Due to Osteoporosis in South Korea :58
Camacho PM / 2020 / American association of clinical endocrinologists/american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update / Endocr Pract 26(Suppl 1):1~46
Health Insurance Servie & Assessment Service Bigdata Hub / Guidance for National Sample Claims Database
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
New Antiresorptive Therapies for Postmenopausal Osteoporosis
대한폐경학회지
2015 .01
-
Teriparatide therapy without surgical treatment for medication-related osteonecrosis of the jaw: a report of two cases
Oral Biology Research
2024 .09
-
골다공증의 약물치료: 2022 update
대한의사협회지
2022 .04
-
Effects of Teriparatide on Treatment Outcomes in Osteoporotic Hip and Pelvic Bone Fractures: Meta-analysis and Systematic Review of Randomized Controlled Trials
Hip and Pelvis
2020 .01
-
How different is the once-weekly teriparatide from the daily one or the same?
Osteoporosis and Sarcopenia
2019 .01
-
Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single
Korean Journal of Neurotrauma
2016 .01
-
The Effect of Postoperative Use of Teriparatide Reducing Screw Loosening in Osteoporotic Patients
대한신경외과학회지
2018 .01
-
Current Role and Application of Teriparatide in Fracture Healing of Osteoporotic Patients: A Systematic Review
대한골대사학회지
2017 .01
-
More than 6 Months of Teriparatide Treatment Was More Effective for Bone Union than Shorter Treatment Following Lumbar Posterolateral Fusion Surgery
Asian Spine Journal
2015 .01
-
Non-operative Treatment of Osteoporotic Thoracolumbar Extension-distraction Fracture Using Teriparatide in Elderly Female Patient with Severe Osteoporosis under Inoperable Condition: A Case Report
Korean Journal of Neurotrauma
2021 .01
-
요추 후외방 유합술 또는 후방 추체간 유합술을 시행한 골다공증 여성 환자에서 Teriparatide의 효과
대한척추외과학회지
2015 .01
-
Adjunctive recombinant human parathyroid hormone agents for the treatment of medication-related osteonecrosis of the jaw: a report of three cases
대한구강악안면외과학회지
2024 .04
-
Utility of radius bone densitometry for the treatment of osteoporosis with once-weekly teriparatide therapy
Osteoporosis and Sarcopenia
2018 .01
-
New treatments of osteoporosis
Osteoporosis and Sarcopenia
2015 .01
-
Evaluation of the effectiveness of oral hormone therapy in osteoporosis animal(rat) model induced by ovariectomy
한국실험동물학회 학술발표대회 논문집
2021 .07
-
Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture risk
Osteoporosis and Sarcopenia
2019 .01
-
Can Three Months of Teriparatide Be One of Treatment Options for Osteoporotic Vertebral Compression Fracture Patients?
Korean Journal of Neurotrauma
2019 .01
-
Post Pregnancy Severe Spinal Osteoporosis with Multiple Vertebral Fractures and Kyphoscoliosis in a Multigravida: A Rare Case with Management
Asian Spine Journal
2015 .01
-
Does Discontinuing Teriparatide Treatment and Replacing It with Bisphosphonate Maintain the Volume of the Bone Fusion Mass after Lumbar Posterolateral Fusion in Women with Postmenopausal Osteoporosis?
Asian Spine Journal
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0